Marshall Wace’s NeoGenomics NEO Stock Holding History

Marshall Wace’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,983	Closed	-$579K	–	3004
2025 Q1	$579K	Buy	+60,983	New	+$761K	﹤0.01%	2022
2022 Q3	–	Sell	-40,477	Closed	-$330K	–	3648
2022 Q2	$330K	Buy	+40,477	New	+$386K	﹤0.01%	2989
2022 Q1	–	Sell	-44,062	Closed	-$1.5M	–	3782
2021 Q4	$1.5M	Buy	+44,062	New	+$1.73M	﹤0.01%	2227
2021 Q2	–	Sell	-4,258	Closed	-$205K	–	2932
2021 Q1	$205K	Buy	+4,258	New	+$222K	﹤0.01%	2254
2020 Q1	–	Sell	-30,707	Closed	-$898K	–	1924
2019 Q4	$898K	Sell	30,707 -298,162	-91%	-$7.1M	0.01%	1011
2019 Q3	$6.29M	Sell	328,869 -1,029,444	-76%	-$24.1M	0.05%	428
2019 Q2	$29.8M	Buy	1,358,313 +1,129,043	+492%	+$24.8M	0.25%	82
2019 Q1	$4.69M	Sell	229,270 -643,025	-74%	-$11.2M	0.04%	486
2018 Q4	$11M	Buy	+872,295	New	+$13M	0.11%	221
2018 Q2	–	Sell	-55,100	Closed	-$450K	–	798
2018 Q1	$450K	Buy	+55,100	New	+$446K	0.02%	390

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Marshall Wace's NEO Position: Q2 2025 in Review

Marshall Wace sold out of NeoGenomics (NEO) in Q2 2025, closing a stake of 60,983 shares — an estimated $579K sold.

Marshall Wace first reported a position in NEO in Q1 2018 and held it in 10 quarters. The position peaked at $29.8M in Q2 2019. 274 funds tracked by Wall St. Rank hold NEO as of Q2 2025.

Marshall Wace reported no remaining NeoGenomics position as of Q2 2025 after selling out during the quarter.
Marshall Wace sold 60,983 NeoGenomics shares in Q2 2025, an estimated $579K.
Marshall Wace first reported a position in NeoGenomics in Q1 2018 and held it in 10 quarters.
Marshall Wace's NeoGenomics position peaked at $29.8M in Q2 2019.
274 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.